Corrigendum: Safety of Semaglutide
- PMID: 34858353
- PMCID: PMC8631750
- DOI: 10.3389/fendo.2021.786732
Corrigendum: Safety of Semaglutide
Abstract
[This corrects the article DOI: 10.3389/fendo.2021.645563.].
Keywords: glucagon-like peptide-1 receptor agonist (GLP-1RA); oral; safety; semaglutide; subcutaneous; type 2 diabetes.
Copyright © 2021 Smits and Van Raalte.
Erratum for
-
Safety of Semaglutide.Front Endocrinol (Lausanne). 2021 Jul 7;12:645563. doi: 10.3389/fendo.2021.645563. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34305810 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources